Bryce Weir to Double-Blind Method
This is a "connection" page, showing publications Bryce Weir has written about Double-Blind Method.
Connection Strength
0.028
-
Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys. J Neurosurg. 1995 Sep; 83(3):503-9.
Score: 0.006
-
A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery. 1995 Jul; 37(1):168-76; discussion 177-8.
Score: 0.006
-
Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg. 1995 May; 82(5):786-90.
Score: 0.006
-
A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm. Neurosurgery. 1989 Feb; 24(2):179-86.
Score: 0.004
-
Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg. 1988 Apr; 68(4):505-17.
Score: 0.004
-
Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983 Mar 17; 308(11):619-24.
Score: 0.003